Author | Dawn L. Hershman, MD | OncLive

Author | Dawn L. Hershman, MD


Dr. Hershman on Late Effects of Intermittent ADT for Prostate Cancer Patients

June 23, 2015

Dawn Hershman, MD, Associate Professor Medicine at Columbia University Medical Center, discusses the late-effects of intermittent androgen deprivation therapy (ADT) to continuous ADT in prostate cancer.

Dr. Hershman on Exercise and AI-Associated Arthralgias

February 07, 2014

Dawn L. Hershman, MD, MS, describes the HOPE study, which looked at the effect of exercise versus usual care on aromatase inhibitor-associated arthralgias (joint pain) in women with breast cancer.

Dr. Hershman on Adherence to Longer Hormonal Therapy

August 01, 2013

Dawn L. Hershman, MD, MS, Associate Professor of Medicine and Epidemiology, Leader, Breast Cancer Program, Herbert Irving Comprehensive Cancer Center, Columbia University, discusses the need for adherence with longer hormonal therapy.

Dr. Hershman on the Use of Compendia-Approved Drugs

June 17, 2013

Dawn L. Hershman, MD, MS, discusses improving care and the use of compendia-approved oncology drugs.